Evolution of the Average Target: Vivendi SE

Evolution of the Target Price: Vivendi SE

Changes in Analyst Recommendations: Vivendi SE

3324a7557f32cb8d637af551dc10a075.v50fvzSXD8E_-iq8ChtlXzdYRqnkGbbn5UmyZ1JhuIc.3qhe3Xu6OKkGnmvqeiMpHnM9EM6sKviDvy_LMjdVyNTmqXmNZNpepQ7MEg~52f801cf074b430c940c82533fedbb27
07-10 Vivendi: EPS upgrade (2026: +343.0%, 2027: +1.6%) Alphavalue
05-29 Vivendi takeover unlikely to rest on an internal email Alphavalue
04-21 Vivendi: A difficult start to the year with limited highlights Alphavalue
04-10 Robertet follows its nose, Sodexo loses its appetite Zonebourse
04-07 Vivendi: UMG/Pershing Square: US listing disguised as a merger Alphavalue
03-24 AlphaValue/Baader Europe Cuts Vivendi EPS Forecasts on Net Income Miss; Price Target Up MT
03-23 Vivendi: Target upgrade by 11.5% Alphavalue
03-12 Vivendi: Continued good progress on cost cutting and deleveraging Alphavalue
11-28 Vivendi takeover prospects dim after French Supreme Court ruling Alphavalue
11-21 AlphaValue Downgrades Recommendation on Vivendi Shares Zonebourse
11-21 Vivendi Down to Reduce from Buy as AlphaValue/Baader Europe Says Bolloré Takeover Prospects 'Nil' MT
11-20 Vivendi faces reduced rating as takeover hopes fade Alphavalue
11-19 Vivendi share slide deepens as mandatory takeover prospects fade Alphavalue
25-10-22 Vivendi: Useless Q3 results Alphavalue
25-10-21 Vivendi nine months revenue at EUR 213 million RE
25-08-08 Update on Recommendation Changes in Paris RE
25-07-31 Vivendi: Good progress on cost cutting and deleveraging Alphavalue
25-07-29 Vivendi: New elements in the Bolloré/Vivendi saga Alphavalue
25-07-21 Vivendi: NAV cut by -2.9% Alphavalue
25-07-18 Vivendi: Increased likelihood of European Commission fine, but investment case remains appealing Alphavalue
25-07-18 A welcomed AMF decision that improves an already very appealing investment case Alphavalue
25-04-28 Vivendi: A good start to the year for Vivendi Alphavalue
25-03-31 Vivendi: A perfect instrument for UMG believers Alphavalue
25-03-11 Vivendi: UBS raises its price target Zonebourse
25-03-11 Vivendi: UBS raises its price target Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+54.15%
+39.49%
+24.12%
+20.66%
+15.17%
+9.53%
+1.09%
- -4.4%
Average +19.98%
Weighted average by Cap. +24.41%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
1.682EUR
Average target price
2.593EUR
Spread / Average Target
+54.15%
High Price Target
3.000EUR
Spread / Highest target
+78.36%
Low Price Target
2.200EUR
Spread / Lowest Target
+30.80%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

alphavalue Alexandre Desprez
CIC Market Solutions
AlphaValue/Baader Europe
Barclays
JPMORGAN Daniel Kerven
ODDO BHF
DEUTSCHE BANK RESEARCH Silvia Cuneo
UBS Richard Eary
CREDIT SUISSE Matthew Walker
GOLDMAN SACHS Lisa Yang
JEFFERIES Jerry Dellis
DEUTSCHE BANK Silvia Cuneo
KEPLER CHEUVREUX Conor O'Shea
HSBC Olivier Moral
MORGAN STANLEY Omar Sheikh
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
1.682EUR
Average target price
2.593EUR
Spread / Average Target
+54.15%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIV Stock
  4. Consensus Vivendi SE